Cooltouch
510(k) K103338
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK103338 | Date1 Nov 2011 | StatusActive |
Recalls
-
- Terminated Z-2915-2016
FDA inspection found that customers who had received devices with promotional material with outside use indications were not notified when labeling was revised to remove these indications.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- PDZ
- Device Class
- Class II
- Regulation
- 21 CFR Part 878.4810
- Advisory Committee
- General, Plastic Surgery
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The CoolTouch is a Laser for Temporary Increase of Clear Nail in Patients with Onychomycosis (FDA classification: PDZ, Class II), designed to improve nail transparency through controlled laser energy application. It operates using Nd:YAG or Ho:YAG laser technology to target fungal infections in nails, aiding in cosmetic and functional improvement. The device is intended for use in clinical settings by trained professionals, adhering to established laser safety protocols. Its regulatory classification reflects its role in non-invasive dermatological and aesthetic treatments.
The CoolTouch is supplied as a reusable medical device, intended for use in sterile conditions within clinical environments such as dermatology or plastic surgery offices. It is not single-use and requires proper maintenance, including cleaning and calibration, to ensure consistent performance and safety. The device is FDA-cleared under a 510(k) submission (K103338) as substantially equivalent to a predicate, with no explicit MRI safety labeling provided. Storage and handling must comply with manufacturer guidelines to preserve functionality and sterility. Authorisation is tied to its classification under FDA regulation 878.4810 for lasers.
Other devices from New Star Lasers, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the CoolTouch laser designed to treat?
The CoolTouch laser is specifically designed to temporarily increase nail clarity in patients with onychomycosis, a fungal nail infection. By applying controlled laser energy (using Nd:YAG or Ho:YAG technology), it targets fungal cells to improve both the cosmetic appearance and functional integrity of the nail. This treatment is non-invasive and intended for use in clinical settings like dermatology or plastic surgery offices.
Is the CoolTouch laser single-use or reusable?
The CoolTouch is a reusable medical device, not intended for single-use. To maintain performance and safety, it requires regular cleaning, calibration, and adherence to sterile conditions during clinical use. Proper maintenance ensures consistent results and compliance with FDA-cleared protocols.
What safety protocols must be followed when using the CoolTouch?
The CoolTouch must be operated by trained professionals in compliance with established laser safety protocols. Since it is FDA-cleared for non-invasive dermatological use, clinical staff must follow manufacturer guidelines for sterile handling, maintenance, and storage. No explicit MRI safety labeling is provided, so MRI compatibility should not be assumed.
How is the CoolTouch laser supplied and stored?
The CoolTouch is supplied as a reusable device for clinical environments, requiring sterile conditions during use. Storage and handling must strictly follow manufacturer instructions to preserve functionality and sterility. Improper storage could compromise performance or introduce contamination risks.
What regulatory classification does the CoolTouch hold?
The CoolTouch is classified under FDA regulation 878.4810 as a Class II laser (product code PDZ) for temporary increase of clear nail in onychomycosis patients. It was cleared via a 510(k) submission (K103338) as substantially equivalent to a predicate device, with review by the Skin and Soft Tissue Devices (SU) advisory committee.